Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1988 May;85(9):3140–3144. doi: 10.1073/pnas.85.9.3140

Cell-surface changes associated with transformation of human hepatocytes to the malignant phenotype.

B Wilson 1, M Ozturk 1, H Takahashi 1, P Motté 1, M Kew 1, K J Isselbacher 1, J R Wands 1
PMCID: PMC280159  PMID: 2834734

Abstract

Hepatocellular carcinoma is one of the leading causes of cancer death in the world. To understand the cellular changes associated with transformation of hepatocytes to the malignant state, we have made several libraries of monoclonal antibodies against the hepatocellular carcinoma cell line FOCUS and have found six antibodies (AF-20, SF-25, SF-31, SF-90, XF-4, and XF-8) that recognize antigens expressed at consistently higher levels on hepatoma cells. We have studied malignant and nontransformed liver tissue from the same individual by using direct 125I-labeled antibody binding and immunoperoxidase staining techniques. For each of these antibodies, we found striking increases in antigen expression on the transformed tissues. These antigens were found to be expressed throughout the tumor and on distant metastases, with little, if any, expression on the nontransformed adjacent liver. These antibodies demonstrate that hepatic transformation may be accompanied by stereotyped and predictable antigenic changes. The uniformity of such antigenic changes suggests an association between these cell-surface alterations and the malignant transformation process.

Full text

PDF
3140

Images in this article

3143Image
on p.3143
3143Image
on p.3143
3143Image
on p.3143
3143Image
on p.3143
3143Image
on p.3143
3143Image
on p.3143

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Carlin C. R., Knowles B. B. Identification of a 90 000-Dalton cell surface glycoprotein with elevated expression in human hepatoma cells. Exp Cell Res. 1983 Sep;147(2):359–367. doi: 10.1016/0014-4827(83)90218-5. [DOI] [PubMed] [Google Scholar]
  2. Carlson R. I., Ben-Porath E., Shouval D., Strauss W., Isselbacher K. J., Wands J. R. Antigenic characterization of human hepatocellular carcinoma. Development of in vitro and in vivo immunoassays that use monoclonal antibodies. J Clin Invest. 1985 Jul;76(1):40–51. doi: 10.1172/JCI111975. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. He L., Isselbacher K. J., Wands J. R., Goodman H. M., Shih C., Quaroni A. Establishment and characterization of a new human hepatocellular carcinoma cell line. In Vitro. 1984 Jun;20(6):493–504. doi: 10.1007/BF02619623. [DOI] [PubMed] [Google Scholar]
  4. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  5. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  6. Moingeon P., Nowill A., Courtois G., Azzarone B., Motte P., Ythier A., Bohuon C., Hercend T. A target structure for a series of human cloned natural killer cell lines is recognized by both anti-TNKtar and 4F2 monoclonal antibodies. J Immunol. 1985 May;134(5):2930–2934. [PubMed] [Google Scholar]
  7. Moriarity D. M., Fox N., Aden D. P., Hoyer J. R., Knowles B. B. Identification of human hepatoma-defined cell surface molecules. Hybridoma. 1983;2(1):39–47. doi: 10.1089/hyb.1983.2.39. [DOI] [PubMed] [Google Scholar]
  8. Reisfeld R. A., Cheresh D. A. Human tumor antigens. Adv Immunol. 1987;40:323–377. doi: 10.1016/s0065-2776(08)60242-4. [DOI] [PubMed] [Google Scholar]
  9. Schneider C., Newman R. A., Sutherland D. R., Asser U., Greaves M. F. A one-step purification of membrane proteins using a high efficiency immunomatrix. J Biol Chem. 1982 Sep 25;257(18):10766–10769. [PubMed] [Google Scholar]
  10. Shih C., Burke K., Chou M. J., Zeldis J. B., Yang C. S., Lee C. S., Isselbacher K. J., Wands J. R., Goodman H. M. Tight clustering of human hepatitis B virus integration sites in hepatomas near a triple-stranded region. J Virol. 1987 Nov;61(11):3491–3498. doi: 10.1128/jvi.61.11.3491-3498.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Shouval D., Eilat D., Carlson R. I., Adler R., Livni N., Wands J. R. Human hepatoma-associated cell surface antigen: identification and characterization by means of monoclonal antibodies. Hepatology. 1985 May-Jun;5(3):347–356. doi: 10.1002/hep.1840050302. [DOI] [PubMed] [Google Scholar]
  12. Wands J. R., Zurawski V. R., Jr High affinity monoclonal antibodies to hepatitis B surface antigen (HBsAg) produced by somatic cell hybrids. Gastroenterology. 1981 Feb;80(2):225–232. [PubMed] [Google Scholar]
  13. Wiedmann K. H., Trejdosiewicz L. K., Southgate J., Thomas H. C. Human hepatocellular carcinoma: cross-reactive and idiotypic antigens associated with malignant transformation of epithelial cells. Hepatology. 1987 May-Jun;7(3):543–550. doi: 10.1002/hep.1840070321. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES